Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
22.69
+0.99 (4.56%)
At close: Mar 10, 2026
SHE:002393 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | - | 184.53 | 361.83 | 93.61 | 122.11 | Upgrade
|
| Depreciation & Amortization | - | 79.85 | 67.31 | 66.12 | 60.2 | Upgrade
|
| Other Amortization | - | 1.35 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.05 | -238.7 | 34.82 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.37 | 15.27 | 1.2 | 1.61 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -102.84 | -15.97 | -23.96 | -19.25 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0 | - | - | - | Upgrade
|
| Other Operating Activities | - | 19.11 | 14.11 | 19 | 14.08 | Upgrade
|
| Change in Accounts Receivable | - | -42.56 | 17.52 | 25.13 | -19.5 | Upgrade
|
| Change in Inventory | - | -21.72 | 8.91 | 11.14 | -4.35 | Upgrade
|
| Change in Accounts Payable | - | -31.66 | -28.28 | 116.95 | 50.22 | Upgrade
|
| Change in Other Net Operating Assets | - | 5.55 | 3.49 | 2.74 | -0.03 | Upgrade
|
| Operating Cash Flow | - | 88.26 | 200.01 | 331.38 | 196.34 | Upgrade
|
| Operating Cash Flow Growth | - | -55.87% | -39.65% | 68.78% | 157.09% | Upgrade
|
| Capital Expenditures | - | -53.75 | -61.72 | -40.91 | -88.24 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.41 | 253.54 | 115.27 | 0.09 | Upgrade
|
| Cash Acquisitions | - | - | -102 | - | - | Upgrade
|
| Investment in Securities | - | -262.61 | -79.96 | -250.04 | - | Upgrade
|
| Other Investing Activities | - | 56.86 | 9.5 | 20.04 | 12.04 | Upgrade
|
| Investing Cash Flow | - | -259.09 | 19.36 | -155.64 | -76.12 | Upgrade
|
| Short-Term Debt Issued | - | 39.75 | - | - | - | Upgrade
|
| Total Debt Issued | - | 39.75 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -47.19 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -6.04 | -0.3 | -0.06 | - | Upgrade
|
| Total Debt Repaid | - | -53.24 | -0.3 | -0.06 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -13.49 | -0.3 | -0.06 | - | Upgrade
|
| Issuance of Common Stock | - | - | 5.55 | 21.01 | - | Upgrade
|
| Repurchase of Common Stock | - | -39.59 | - | - | - | Upgrade
|
| Common Dividends Paid | - | -121.03 | -54.74 | -54.74 | -18.25 | Upgrade
|
| Other Financing Activities | - | -0.07 | 0.67 | - | - | Upgrade
|
| Financing Cash Flow | - | -174.18 | -48.82 | -33.79 | -18.25 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | - | -345 | 170.54 | 141.95 | 101.97 | Upgrade
|
| Free Cash Flow | - | 34.51 | 138.29 | 290.47 | 108.1 | Upgrade
|
| Free Cash Flow Growth | - | -75.04% | -52.39% | 168.71% | - | Upgrade
|
| Free Cash Flow Margin | - | 2.58% | 11.99% | 25.33% | 9.90% | Upgrade
|
| Free Cash Flow Per Share | - | 0.14 | 0.54 | 1.13 | 0.42 | Upgrade
|
| Cash Income Tax Paid | - | 154.11 | 195.53 | 133.17 | 126.12 | Upgrade
|
| Levered Free Cash Flow | - | 17.39 | 24.69 | 302.3 | 8.51 | Upgrade
|
| Unlevered Free Cash Flow | - | 19.05 | 25.16 | 302.85 | 8.71 | Upgrade
|
| Change in Working Capital | - | -94.16 | -3.83 | 140.6 | 17.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.